drugset / Trial / NCT06919991

Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

NCT06919991

Phase 1 Completed 14 enrolled Arcus Biosciences, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the effects of multiple doses of itraconazole (a strong CYP3A4 inhibitor) on single dose PK of casdatifan in healthy adults and to assess the effects of multiple doses of phenytoin (a strong CYP3A4 inducer) on single dose PK of casdatifan in healthy adults.

Timeline

Start
2025-05-02
Primary completion
2025-10-18
Completion
2025-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Casdatifan Small molecule
Subject Itraconazole Small molecule
Subject Phenytoin Unknown

Indications

No indication recorded.